Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.820
+0.060 (3.41%)
At close: Oct 9, 2025, 4:00 PM EDT
1.830
+0.010 (0.55%)
Pre-market: Oct 10, 2025, 7:22 AM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $211.53 million as of October 10, 2025. Its market cap has increased by 76.57% in one year.
Market Cap
211.53M
Enterprise Value
14.93M
1-Year Change
76.57%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $211.53M, a decrease of -47.67%. That is a compound annual growth rate of -5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 204.60M | 28.68% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |